The mechanism of action of PD-1 inhibitors lies in blocking the interaction between PD-1 and its ligands PD-L1 and PD-L2, relieving the suppressed state of T cells and restoring their ability to kill tumor cells (33). This evidence concerns the gene CD274 and neoplasm.